Rubius Therapeutics Inc.

THE STORY: Cambridge, Mass.-based Rubius Therapeutics Inc. was founded in 2013 with the aim to transform cancer treatments and autoimmune diseases through new cellular medicines. In 2018, Rubius purchased a 135,000-square-foot manufacturing facility in Smithfield to produce red cell therapeutics. The company planned to invest up to $155 million over five years and expected to…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display